Autoimmune disorders, rheumatoid arthritis, systemic inflammation, and immune dysregulation
206 articles
New research reveals atopic dermatitis has multiple biological subtypes, each requiring personalized treatment approaches.
New research identifies Lp-PLA2 enzyme as therapeutic target for deadly lung disease affecting millions of workers worldwide.
Scientists develop potent α5β1 integrin inhibitor for inhalation therapy, offering new approach for severe asthma patients.
New spatial multiomics study maps cellular interactions in systemic sclerosis, revealing fibroblast-macrophage dynamics.
New research reveals how IL-35 therapy prevents neutrophil trap formation, offering hope for cigarette smoke-worsened asthma.
Review examines immunosuppressive drugs like cyclosporine and tacrolimus, highlighting new applications and safety management strategies.
New research reveals how IGF2BP3 protein promotes inflammation and tissue damage in rheumatoid arthritis through RNA modifications.
Expert commentary on pemphigus foliaceus, a rare autoimmune blistering disease affecting skin health and immune function.
Delphi study of 166 Italian neurologists establishes guidelines for individualized MS therapy based on patient needs and drug characteristics.
65 neurologists from 54 Italian MS centers agree on when and how to use high-efficacy therapies to prevent irreversible disability.
Latest advances in molecular diagnostics may revolutionize how clinicians detect and manage antibiotic-resistant gonorrhea infections.
New research reveals how necroptosis activates immune pathways, offering targets for inflammatory bowel disease treatment.
